We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+15.94%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.73B
AUM Growth
+$152M
Cap. Flow
-$38.6M
Cap. Flow %
-2.23%
Top 10 Hldgs %
25.39%
Holding
270
New
10
Increased
28
Reduced
188
Closed
10

Sector Composition

Rank Sector Weight
1 Healthcare 30.1%
2 Technology 23.78%
3 Industrials 19.23%
4 Consumer Discretionary 6.36%
5 Communication Services 6.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
THR
101
DELISTED
Thermon Group Holdings
THR
$3.9M 0.23%
119,649
-30,593
-20% -$912K
HLIT icon
102
Harmonic Inc
HLIT
$1.28B
$3.88M 0.22%
297,217
-14,503
-5% -$155K
LNTH icon
103
Lantheus
LNTH
$6.59B
$3.8M 0.22%
61,348
-1,837
-3% -$124K
ADUS icon
104
Addus HomeCare
ADUS
$2.23B
$3.75M 0.22%
+40,418
New +$3.51M
HAYN
105
DELISTED
Haynes International, Inc.
HAYN
$3.74M 0.22%
65,604
-3,439
-5% -$166K
GATX icon
106
GATX Corp
GATX
$6.27B
$3.71M 0.21%
30,853
-639
-2% -$70.5K
CBZ icon
107
CBIZ
CBZ
$2.96B
$3.7M 0.21%
59,127
-2,590
-4% -$146K
SLP icon
108
Simulations Plus
SLP
$371M
$3.69M 0.21%
82,432
-3,971
-5% -$157K
IRMD icon
109
iRadimed
IRMD
$1.18B
$3.65M 0.21%
76,877
-629
-0.8% -$26.4K
MTRN icon
110
Materion
MTRN
$6.04B
$3.61M 0.21%
27,717
-499
-2% -$54.7K
KTOS icon
111
Kratos Defense & Security Solutions
KTOS
$11.4B
$3.59M 0.21%
176,717
+22,654
+15% +$416K
LUCK
112
Lucky Strike Entertainment
LUCK
$911M
$3.58M 0.21%
253,028
-5,465
-2% -$60K
ANIP icon
113
ANI Pharmaceuticals
ANIP
$1.78B
$3.58M 0.21%
64,920
-3,283
-5% -$181K
IWO icon
114
iShares Russell 2000 Growth ETF
IWO
$15B
$3.48M 0.2%
13,814
+11,771
+576% +$2.65M
HURN icon
115
Huron Consulting
HURN
$2.42B
$3.42M 0.2%
33,224
-1,426
-4% -$146K
LQDT icon
116
Liquidity Services
LQDT
$1.32B
$3.4M 0.2%
197,395
-11,397
-5% -$217K
PNTG icon
117
Pennant Group
PNTG
$1.36B
$3.35M 0.19%
240,343
-12,615
-5% -$158K
PRMW
118
DELISTED
Primo Water Corporation
PRMW
$3.27M 0.19%
217,276
+46,942
+28% +$670K
VITL icon
119
Vital Farms
VITL
$525M
$3.22M 0.19%
+205,096
New +$2.59M
EHC icon
120
Encompass Health
EHC
$12.4B
$3.19M 0.19%
47,886
-920
-2% -$59.6K
PGNY icon
121
Progyny
PGNY
$2.2B
$3.13M 0.18%
84,125
+17,225
+26% +$578K
ZIMV
122
DELISTED
ZimVie
ZIMV
$3.13M 0.18%
176,102
-9,683
-5% -$97.6K
LASR icon
123
nLIGHT
LASR
$3.17B
$3.1M 0.18%
229,863
-10,469
-4% -$117K
TNDM icon
124
Tandem Diabetes Care
TNDM
$1.56B
$3.09M 0.18%
104,430
-2,946
-3% -$61.1K
HLX icon
125
Helix Energy Solutions
HLX
$1.41B
$3.05M 0.18%
296,341
-54,055
-15% -$537K

Similar funds

Rice Hall James & Associates's Q4 2023 Portfolio in Review

As of Q4 2023, Rice Hall James & Associates held 270 positions worth $1.73B, up 9.7% from $1.57B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Rice Hall James & Associates's Q4 2023 filing shows 10 new, 28 increased, 188 reduced and 10 closed positions. Its largest new stake was Addus HomeCare: 40,418 shares worth $3.75M. The largest sale was Bed Bath & Beyond, an estimated $11.2M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 28% a quarter earlier, followed by Technology and Industrials.

  • Rice Hall James & Associates's largest Q4 2023 buy was Addus HomeCare: 40,418 shares worth $3.75M.
  • Rice Hall James & Associates added most to Establishment Labs in Q4 2023, an estimated $11.2M increase.
  • Rice Hall James & Associates's biggest Q4 2023 reduction was Bed Bath & Beyond, cutting an estimated $11.2M.
  • Rice Hall James & Associates fully exited NextGen Healthcare, Inc. Common Stock in Q4 2023, selling an estimated $9.14M.
  • Rice Hall James & Associates's ten largest holdings make up 25% of its $1.73B portfolio in Q4 2023.
  • Rice Hall James & Associates opened 10 new positions and closed 10 in Q4 2023.
  • Rice Hall James & Associates's portfolio value rose 9.7% quarter-over-quarter to $1.73B.

Based on Rice Hall James & Associates's 13F filing for Q4 2023, filed 9 Feb 2024.